Vesalius Cardiovascular

Vesalius Cardiovascular is a biomedical research and development corporation, focusing on the treatment of structural heart disease, specifically mitral valve disease causing mitral regurgitation.

Stage: HATCH Venture Builder

Visit our website

Follow on social

Find us on Linkedin

Founders

Peter Skarsgard

Get in touch

Connect

Explore our programs

Learn more

Locations

We are located across UBC Point Grey and Robson Square Campus. Learn more about our locations

We acknowledge that the UBC Point Grey and Robson Square campuses are situated on the traditional, ancestral, and unceded territory of the xʷməθkʷəy̓əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lō and Səl̓ílwətaʔ/Selilwitulh (Tsleil- Waututh) Nations.

About us

entrepreneurship@UBC propels UBC innovations out into the world through venture creation, providing UBC students, faculty members and staff with the resources, networks, and funding they need to succeed.

We are a part of Innovation UBC in the Vice-President, Research and Innovation (VPRI) portfolio

Vesalius Cardiovascular